Requip Depot 8 mg Norway - Norway - Statens legemiddelverk

requip depot 8 mg

glaxosmithkline as - ropinirolhydroklorid - depottablett - 8 mg

Ropinirol Mylan 1 mg Norway - Norway - Statens legemiddelverk

ropinirol mylan 1 mg

mylan ab - ropinirolhydroklorid - tablett, filmdrasjert - 1 mg

Ropinirol Mylan 0.5 mg Norway - Norway - Statens legemiddelverk

ropinirol mylan 0.5 mg

mylan ab - ropinirolhydroklorid - tablett, filmdrasjert - 0.5 mg

Ropinirol Mylan 5 mg Norway - Norway - Statens legemiddelverk

ropinirol mylan 5 mg

mylan ab - ropinirolhydroklorid - tablett, filmdrasjert - 5 mg

Anagrelide Bluefish 0.5 mg Norway - Norway - Statens legemiddelverk

anagrelide bluefish 0.5 mg

bluefish pharmaceuticals ab - anagrelidhydroklorid - kapsel, hard - 0.5 mg

Protaminsulfat LEO Pharma 1400 anti-heparin IE/ ml Norway - Norway - Statens legemiddelverk

protaminsulfat leo pharma 1400 anti-heparin ie/ ml

leo pharma (2) - protaminsulfat - injeksjons-/infusjonsvæske, oppløsning - 1400 anti-heparin ie/ ml

Ropivacain Fresenius Kabi 2 mg/ ml Norway - Norway - Statens legemiddelverk

ropivacain fresenius kabi 2 mg/ ml

fresenius kabi norge as - halden - ropivakainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 2 mg/ ml

Ropivacain Fresenius Kabi 7.5 mg/ ml Norway - Norway - Statens legemiddelverk

ropivacain fresenius kabi 7.5 mg/ ml

fresenius kabi norge as - halden - ropivakainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 7.5 mg/ ml

Ropivacain Fresenius Kabi 10 mg/ ml Norway - Norway - Statens legemiddelverk

ropivacain fresenius kabi 10 mg/ ml

fresenius kabi norge as - halden - ropivakainhydrokloridmonohydrat - injeksjonsvæske, oppløsning - 10 mg/ ml

Dabigatran Etexilate Accord Kesatuan Eropah - Norway - EMA (European Medicines Agency)

dabigatran etexilate accord

accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - antithrombotic agents - prevention of venous thromboembolic events.